AMC SLE antibodies.
Recruiting
- Conditions
- Systemic Lupus Erythematosus, SLE
- Registration Number
- NL-OMON20754
- Lead Sponsor
- AMC amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Male and female patients with a diagnosis of SLE and whose serum contains autoantibodies against type I IFNs.
Exclusion Criteria
1. Use of or history of use of B cell-directed therapies;
2. Pregnancy.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary goal is to investigate the possibility of generating fully human monoclonal antibodies against type I interferons (IFNs) from B cells of SLE patients.
- Secondary Outcome Measures
Name Time Method